{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/otitis-externa/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"d74a591d-a4fa-5fa7-9a79-11341d8ad57c","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 74a4012b-f65d-4e1a-92e5-cc6bc26b1b09 --><h2>Update</h2><!-- end field 74a4012b-f65d-4e1a-92e5-cc6bc26b1b09 -->","summary":null,"htmlStringContent":"<!-- begin item 287fd9fd-9afa-4c1a-8466-80ba5b8d7330 --><!-- end item 287fd9fd-9afa-4c1a-8466-80ba5b8d7330 -->","topic":{"id":"f876df90-ac8c-5343-ac27-cf0dce71d872","topicId":"0999db7d-67e0-4462-a7d7-c1cd5f57cf6a","topicName":"Otitis externa","slug":"otitis-externa","lastRevised":"Last revised in February 2018","chapters":[{"id":"66707be8-e82b-56aa-a7d4-2e83fd4e34f9","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"cc9f278a-f789-50fb-a43c-1b9fde28ef7f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"042a16b9-3050-5ecb-9199-e9f18527c183","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"736969ef-5779-5f8d-b3c8-95bc2137ea11","slug":"changes","fullItemName":"Changes"},{"id":"d74a591d-a4fa-5fa7-9a79-11341d8ad57c","slug":"update","fullItemName":"Update"}]},{"id":"922f046d-5114-504a-b7dd-1754b6b9de95","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"07126be4-c022-5eca-b29c-7b3bf9638295","slug":"goals","fullItemName":"Goals"},{"id":"fa385cc8-0093-54cd-ab27-8bf1de604bd7","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"5717d539-e1a2-5f48-9c65-a6e1c3523910","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d8e4c4a2-74ce-589f-856b-dfd3f0c0e8d9","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b72bcdb9-0860-5e4e-ac10-b0ddef3274ed","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"dc6ecfda-2678-5466-b11f-c04e4a210a6c","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"c4e7ed77-cefa-531a-a475-7af487f17915","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"b6eaf075-9623-547f-88d8-987fc90c5bdf","slug":"definition","fullItemName":"Definition"},{"id":"c8342f48-2446-51c8-b164-710650b2b937","slug":"causes","fullItemName":"Causes"},{"id":"dfaffdb8-3a14-5de7-ae1f-aab5dd341ee9","slug":"complications","fullItemName":"Complications"},{"id":"a5cb2def-cfd9-5728-95fa-4e9bbceb7fd8","slug":"prognosis","fullItemName":"Prognosis"},{"id":"63c036e7-6c79-5164-bded-0583fa30260b","slug":"prevalence","fullItemName":"Prevalence"}]},{"id":"8aa1bc32-b762-5d5a-bfe3-378af9c545f3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c7df346e-5420-50ae-98ff-4e00234699d9","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"f3f8f6dd-87d1-5688-8f98-84eb3ec59ca5","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1851ae55-865c-5488-902c-54822a2a76dd","fullItemName":"Management","slug":"management","subChapters":[{"id":"9f7ce67c-9805-5fef-a1f9-cc88a9085674","slug":"localized-otitis-externa","fullItemName":"Scenario: Localized otitis externa"},{"id":"d753f65b-ae51-5d11-8b85-4d833a89a428","slug":"acute-diffuse-otitis-externa","fullItemName":"Scenario: Acute diffuse otitis externa"},{"id":"7f39d3cc-526b-51bc-b091-6399e805f3cb","slug":"chronic-diffuse-otitis-externa","fullItemName":"Scenario: Chronic diffuse otitis externa"}]},{"id":"aa30911a-20a0-5191-ba4e-f48610d404b2","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"e43fc276-0f45-52d9-97a9-394af935add3","slug":"topical-ear-preparations","fullItemName":"Topical ear preparations"},{"id":"b49a03f2-59c1-56ed-b894-9e01ce84d1a8","slug":"oral-analgesics","fullItemName":"Oral analgesics"},{"id":"fd97664d-7f15-5f36-a10c-7bcad2d057f2","slug":"oral-flucloxacillin","fullItemName":"Oral flucloxacillin"},{"id":"b186879f-d6d6-5afa-84d8-845ba42605c1","slug":"oral-clarithromycin","fullItemName":"Oral clarithromycin"}]},{"id":"8c363337-fc91-521b-a609-58b9b0ba4d8b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9feebcb7-db7f-5a9f-a9a7-89f401ebca13","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8fc4ebd8-033e-5184-bb1e-cc1bd7de86e2","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7580e3ff-a6f6-5f7b-9254-6772074d8d7b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5162da22-b23f-5934-87a8-4aa96029fcde","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"babd7947-def4-5d00-a46e-c68902688a88","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"18fd5166-b294-56f8-8cf1-c2e4e2bfa31d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ae1ef912-929f-5085-9b08-d75ce3e016b7","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"042a16b9-3050-5ecb-9199-e9f18527c183","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"9041dcb8-a32d-5692-be9c-a1dd0f19032f","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 6995c4f4-c054-4dc5-8c2c-55e50413c11f --><h3>New evidence</h3><!-- end field 6995c4f4-c054-4dc5-8c2c-55e50413c11f -->","summary":null,"htmlStringContent":"<!-- begin item 1d929095-7e52-41bc-b239-21d0793f1d23 --><!-- begin field f3f08159-5534-4017-a403-83be60b17833 --><h3>Evidence-based guidelines</h3><!-- end field f3f08159-5534-4017-a403-83be60b17833 --><!-- begin field 6777225a-d565-43ec-8197-a2cb69396bad --><p>No new evidence-based guidelines since 1 October 2016.</p><!-- end field 6777225a-d565-43ec-8197-a2cb69396bad --><!-- begin field b486d6e9-8bc2-40cc-9ed9-d632504420b6 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field b486d6e9-8bc2-40cc-9ed9-d632504420b6 --><!-- begin field d59e333e-28d6-467c-bcec-563f49555edf --><p>No new HTAs since 1 October 2016.</p><!-- end field d59e333e-28d6-467c-bcec-563f49555edf --><!-- begin field 325727b2-bd68-4ea3-a59d-b90f410e04d9 --><h3>Economic appraisals</h3><!-- end field 325727b2-bd68-4ea3-a59d-b90f410e04d9 --><!-- begin field fb7095fe-aa55-4d39-a9a7-aac27611e66d --><p>No new economic appraisals relevant to England since 1 October 2016.</p><!-- end field fb7095fe-aa55-4d39-a9a7-aac27611e66d --><!-- begin field c650a53a-ecb3-4f96-b278-d51d54ab435c --><h3>Systematic reviews and meta-analyses</h3><!-- end field c650a53a-ecb3-4f96-b278-d51d54ab435c --><!-- begin field a52ac7e8-1adb-48e7-b321-db975ab268b3 --><p>No new systematic reviews or meta-analyses since 1 October 2016.</p><!-- end field a52ac7e8-1adb-48e7-b321-db975ab268b3 --><!-- begin field 61a3b3f6-944b-4546-a797-353fede069d4 --><h3>Primary evidence</h3><!-- end field 61a3b3f6-944b-4546-a797-353fede069d4 --><!-- begin field 7de70c9e-3549-48ce-a32d-09d345fd7435 --><p>No new high quality randomized controlled trials since 1 October 2016.</p><!-- end field 7de70c9e-3549-48ce-a32d-09d345fd7435 --><!-- end item 1d929095-7e52-41bc-b239-21d0793f1d23 -->","subChapters":[]},{"id":"8666c2e4-8bbf-5429-af30-c1c4a3b81bb7","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field f0676a77-039b-418e-95bc-87eeab29de1e --><h3>New policies</h3><!-- end field f0676a77-039b-418e-95bc-87eeab29de1e -->","summary":null,"htmlStringContent":"<!-- begin item d053cf0a-ea0e-4adb-b1a6-436964032ab4 --><!-- begin field 81bf33e1-7215-43c5-832b-e6c8b58bb4bc --><p>No new national policies or guidelines since 1 October 2016.</p><!-- end field 81bf33e1-7215-43c5-832b-e6c8b58bb4bc --><!-- end item d053cf0a-ea0e-4adb-b1a6-436964032ab4 -->","subChapters":[]},{"id":"aa341703-a1d3-5463-b2bd-264c66189b37","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field 55cf1c2f-907f-4de0-9cdc-2dc1999a6217 --><h3>New safety alerts</h3><!-- end field 55cf1c2f-907f-4de0-9cdc-2dc1999a6217 -->","summary":null,"htmlStringContent":"<!-- begin item fc4772e2-3812-4153-a729-c33106ad774a --><!-- begin field dc041a62-046a-4332-9e30-08863b3c6353 --><p>No new safety alerts since 1 October 2016.</p><!-- end field dc041a62-046a-4332-9e30-08863b3c6353 --><!-- end item fc4772e2-3812-4153-a729-c33106ad774a -->","subChapters":[]},{"id":"64589720-0c1f-5cfd-9c6d-5062cee9fc2d","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 36c6db80-aa2f-4af0-9d49-5f99700a7fda --><h3>Changes in product availability</h3><!-- end field 36c6db80-aa2f-4af0-9d49-5f99700a7fda -->","summary":null,"htmlStringContent":"<!-- begin item 18be1454-9649-4106-aee4-b9d42432cc30 --><!-- begin field 3d06db29-3a6d-4044-93e4-928f144fbf8c --><ul><li>New product availability - Cetraxal® (ciprofloxacin 2mg/ml ear drops solution in a single-dose container) is now available. [<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-externa/references/\">ABPI, 2018</a>] </li></ul><!-- end field 3d06db29-3a6d-4044-93e4-928f144fbf8c --><!-- end item 18be1454-9649-4106-aee4-b9d42432cc30 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}